Topics

Astellas partners with Adaptimmune in latest move into cell therapy

14:53 EST 15 Jan 2020 | MedCity News

The companies will work to develop allogeneic CAR-T and T-cell receptor therapies. Astellas has made multiple moves into cell and gene therapy in the past month.

Original Article: Astellas partners with Adaptimmune in latest move into cell therapy

NEXT ARTICLE

More From BioPortfolio on "Astellas partners with Adaptimmune in latest move into cell therapy"

Quick Search

Relevant Topic

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...